Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IINN
IINN logo

IINN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Inspira Technologies Oxy BHN Ltd (IINN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.590
1 Day change
17.86%
52 Week Range
1.650
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Inspira Technologies Oxy BHN Ltd (IINN) does not currently present a strong buy opportunity for a beginner investor with a long-term strategy. The stock shows no significant trading trends, lacks positive financial growth, and has no active trading signals. While there are potential catalysts in its AME technology adoption, the company's financials and market performance suggest a cautious approach.

Technical Analysis

The MACD is positive and expanding, indicating slight bullish momentum, but the RSI is neutral at 57.607, showing no clear overbought or oversold conditions. Moving averages are converging, and the stock is trading below its pivot level of 0.48, with key support at 0.405 and resistance at 0.555. Overall, the technical indicators suggest a neutral to slightly bearish trend.

Positive Catalysts

  • The company has successfully delivered its AME system to a Tier-1 U.S. defense customer, establishing a recurring revenue stream. Additionally, the implementation of AME technology with a major U.S. client could validate the technology and enhance market share in quantum computing.

Neutral/Negative Catalysts

  • The stock has experienced consistent price declines in pre-market, regular market, and post-market trading (-2.60%, -2.56%, and -8.99%, respectively). Financials show no revenue growth, with a net income of -$3,008,000 and an EPS of -0.45, indicating poor profitability.

Financial Performance

In Q4 2023, the company reported no revenue growth (0% YoY), a net income of -$3,008,000, and an EPS of -0.45. Gross margin increased to 0.69, but overall financial performance remains weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes are available for IINN.

Wall Street analysts forecast IINN stock price to rise
Analyst Rating
0
Wall Street analysts forecast IINN stock price to rise
Buy
Hold
Sell
0
Current: 0.498
sliders
Low
0
Averages
0
High
0
0
Current: 0.498
sliders
Low
0
Averages
0
High
0
Litchfield Hills
Theodore O'Neill
Buy
initiated
$2
AI Analysis
2025-06-02
Reason
Litchfield Hills
Theodore O'Neill
Price Target
$2
AI Analysis
2025-06-02
initiated
Buy
Reason
Litchfield Hills analyst Theodore O'Neill initiated coverage of Inspira Technologies with a Buy rating and $2 price target. Inspira is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions, the analyst tells investors in a research note. The firm says the company has a "well-protected technology moat" that includes both patented technology and technical trade secrets.

People Also Watch